398 related articles for article (PubMed ID: 27890782)
1. Bromodomain Histone Readers and Cancer.
Jain AK; Barton MC
J Mol Biol; 2017 Jun; 429(13):2003-2010. PubMed ID: 27890782
[TBL] [Abstract][Full Text] [Related]
2. Small molecule inhibitors of bromodomain-acetyl-lysine interactions.
Brand M; Measures AR; Wilson BG; Cortopassi WA; Alexander R; Höss M; Hewings DS; Rooney TP; Paton RS; Conway SJ
ACS Chem Biol; 2015 Jan; 10(1):22-39. PubMed ID: 25549280
[TBL] [Abstract][Full Text] [Related]
3. Selective recognition of acetylated histones by bromodomains in transcriptional co-activators.
Hassan AH; Awad S; Al-Natour Z; Othman S; Mustafa F; Rizvi TA
Biochem J; 2007 Feb; 402(1):125-33. PubMed ID: 17049045
[TBL] [Abstract][Full Text] [Related]
4. Biological function and histone recognition of family IV bromodomain-containing proteins.
Lloyd JT; Glass KC
J Cell Physiol; 2018 Mar; 233(3):1877-1886. PubMed ID: 28500727
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between chromatin acetylation and SUMOylation of tripartite motif-containing protein 24 (TRIM24) impacts cell adhesion.
Appikonda S; Thakkar KN; Shah PK; Dent SYR; Andersen JN; Barton MC
J Biol Chem; 2018 May; 293(19):7476-7485. PubMed ID: 29523690
[TBL] [Abstract][Full Text] [Related]
6. The bromodomain: from epigenome reader to druggable target.
Sanchez R; Meslamani J; Zhou MM
Biochim Biophys Acta; 2014 Aug; 1839(8):676-85. PubMed ID: 24686119
[TBL] [Abstract][Full Text] [Related]
7. Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.
Romero FA; Taylor AM; Crawford TD; Tsui V; Côté A; Magnuson S
J Med Chem; 2016 Feb; 59(4):1271-98. PubMed ID: 26572217
[TBL] [Abstract][Full Text] [Related]
8. Functional Roles of Bromodomain Proteins in Cancer.
Boyson SP; Gao C; Quinn K; Boyd J; Paculova H; Frietze S; Glass KC
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298819
[TBL] [Abstract][Full Text] [Related]
9. Targeting bromodomains: epigenetic readers of lysine acetylation.
Filippakopoulos P; Knapp S
Nat Rev Drug Discov; 2014 May; 13(5):337-56. PubMed ID: 24751816
[TBL] [Abstract][Full Text] [Related]
10. YEATS Domain-A Histone Acylation Reader in Health and Disease.
Zhao D; Li Y; Xiong X; Chen Z; Li H
J Mol Biol; 2017 Jun; 429(13):1994-2002. PubMed ID: 28300602
[TBL] [Abstract][Full Text] [Related]
11. An apicomplexan bromodomain protein, TgBDP1, associates with diverse epigenetic factors to regulate essential transcriptional processes in
Fleck K; McNutt S; Chu F; Jeffers V
mBio; 2023 Aug; 14(4):e0357322. PubMed ID: 37350586
[TBL] [Abstract][Full Text] [Related]
12. Biochemical profiling of histone binding selectivity of the yeast bromodomain family.
Zhang Q; Chakravarty S; Ghersi D; Zeng L; Plotnikov AN; Sanchez R; Zhou MM
PLoS One; 2010 Jan; 5(1):e8903. PubMed ID: 20126658
[TBL] [Abstract][Full Text] [Related]
13. Structural insight into the recognition of acetylated histone H3K56ac mediated by the bromodomain of CREB-binding protein.
Xu L; Cheng A; Huang M; Zhang J; Jiang Y; Wang C; Li F; Bao H; Gao J; Wang N; Liu J; Wu J; Wong CCL; Ruan K
FEBS J; 2017 Oct; 284(20):3422-3436. PubMed ID: 28815970
[TBL] [Abstract][Full Text] [Related]
14. The exploitation of FRET probes to track bromodomain/histone interactions in cells for bromodomain inhibitors.
Sasaki K; Yoshida M
Drug Discov Today Technol; 2016 Mar; 19():51-56. PubMed ID: 27769358
[TBL] [Abstract][Full Text] [Related]
15. The transcriptional regulation role of BRD7 by binding to acetylated histone through bromodomain.
Peng C; Zhou J; Liu HY; Zhou M; Wang LL; Zhang QH; Yang YX; Xiong W; Shen SR; Li XL; Li GY
J Cell Biochem; 2006 Mar; 97(4):882-92. PubMed ID: 16265664
[TBL] [Abstract][Full Text] [Related]
16. Bromodomains: Structure, function and pharmacology of inhibition.
Ferri E; Petosa C; McKenna CE
Biochem Pharmacol; 2016 Apr; 106():1-18. PubMed ID: 26707800
[TBL] [Abstract][Full Text] [Related]
17. Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.
Hewings DS; Rooney TP; Jennings LE; Hay DA; Schofield CJ; Brennan PE; Knapp S; Conway SJ
J Med Chem; 2012 Nov; 55(22):9393-413. PubMed ID: 22924434
[TBL] [Abstract][Full Text] [Related]
18. Insights into the Molecular Mechanisms of Histone Code Recognition by the BRPF3 Bromodomain.
Barman S; Roy A; Bardhan I; Kandasamy T; Shivani S; Sudhamalla B
Chem Asian J; 2021 Nov; 16(21):3404-3412. PubMed ID: 34448544
[TBL] [Abstract][Full Text] [Related]
19. BET Bromodomain as a Target of Epigenetic Therapy.
Noguchi-Yachide T
Chem Pharm Bull (Tokyo); 2016; 64(6):540-7. PubMed ID: 27250788
[TBL] [Abstract][Full Text] [Related]
20. Role of Histone Acetylation in Cell Cycle Regulation.
Koprinarova M; Schnekenburger M; Diederich M
Curr Top Med Chem; 2016; 16(7):732-44. PubMed ID: 26303420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
